| Stage | UTI | % of rev | IMAX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $219M | 100.00% | $103M | 100.00% | UTI ×2.13 |
| Gross profit | $219M | 100.00% | $63M | 61.16% | UTI +38.8pp |
| Operating income | $3M | 1.48% | $21M | 20.20% | IMAX +18.7pp |
| Pre-tax income | $3M | 1.42% | $19M | 18.88% | IMAX +17.5pp |
| Net income | $2M | 1.04% | $16M | 15.47% | IMAX +14.4pp |
| Stage | UTI | IMAX | Gap · A − B |
|---|---|---|---|
| Revenue | $219M100.00% | $103M100.00% | UTI ×2.13 |
| Gross profit | 100.00%$219M | 61.16%$63M | UTI +38.8pp |
| Operating income | 1.48%$3M | 20.20%$21M | IMAX +18.7pp |
| Pre-tax income | 1.42%$3M | 18.88%$19M | IMAX +17.5pp |
| Net income |
| 1.04%$2M |
| 15.47%$16M |
| IMAX +14.4pp |
No shared counterparties.